{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:30:50Z","timestamp":1793640650521,"version":"4.5.1"},"reference-count":33,"publisher":null,"issue":"1","license":[{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/lib.ossn.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kardiologiia"],"DOI":"10.18087\/cardio.2022.1.n1890","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T01:56:17Z","timestamp":1644976577000},"page":"24-31","source":"Crossref","is-referenced-by-count":2,"title":["To study the dynamics of serum levels of vascular remodeling in patients with hypertension, including in combination with type 2 diabetes mellitus during 12\u2011month therapy with perindopril A"],"prefix":"10.68900","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6999-0602","authenticated-orcid":true,"given":"E. A.","family":"Privalova","sequence":"first","affiliation":[{"name":"I.M. Sechenov First Moscow Medical University (Sechenov University), Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3014-6129","authenticated-orcid":true,"given":"Yu. N.","family":"Belenkov","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow Medical University (Sechenov University), Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4994-8500","authenticated-orcid":true,"given":"Yu. A.","family":"Danilogorskaya","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow Medical University (Sechenov University), Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-192X","authenticated-orcid":true,"given":"E. A.","family":"Zheleznykh","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow Medical University (Sechenov University), Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4778-7755","authenticated-orcid":true,"given":"M. V.","family":"Kozhevnikova","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow Medical University (Sechenov University), Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8547-8673","authenticated-orcid":true,"given":"V. Y.","family":"Zektser","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow Medical University (Sechenov University), Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3391-0193","authenticated-orcid":true,"given":"A. S.","family":"Lishuta","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow Medical University (Sechenov University), Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6817-6270","authenticated-orcid":true,"given":"I. S.","family":"Ilgisonis","sequence":"additional","affiliation":[{"name":"I.M. Sechenov First Moscow Medical University (Sechenov University), Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":null,"published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Yasmin, Wallace S, McEniery CM, Dakham Z, Pusalkar P, Maki-Petaja K et al. Matrix Metalloproteinase-9 (MMP-9), MMP-2, and Serum Elastase Activity Are Associated With Systolic Hypertension and Arterial Stiffness. Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25(2):372\u20138. DOI: 10.1161\/01.ATV.0000151373.33830.41","DOI":"10.1161\/01.ATV.0000151373.33830.41"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Vatutin N.T., Sklyannaya E.V. Prevalence of arterial hypertension and risk factors in young adults. Archive of internal medicine. 2017;7(1):30\u20134. DOI: 10.20514\/2226-6704-2017-7-1-30-34","DOI":"10.20514\/2226-6704-2017-7-1-30-34"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Dedov I.I., Shestakova M.V., Mayorov A.Yu., Vikulova O.K., Galstyan G.R., Kuraeva T.L. et al. Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 8th edition. Diabetes mellitus. 2017;20(1S):1\u2013121. DOI: 10.14341\/DM20171S8","DOI":"10.14341\/DM20171S8"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Kobalava Zh.D., Konradi A.O., Nedogoda S.V., Shlyakhto E.V., Arutyunov G.P., Baranova E.I. et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):149\u2013 218. DOI: 10.15829\/1560-4071-2020-3-3786","DOI":"10.15829\/1560-4071-2020-3-3786"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Harvey A, Montezano AC, Lopes RA, Rios F, Touyz RM. Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications. Canadian Journal of Cardiology. 2016;32(5):659\u201368. DOI: 10.1016\/j.cjca.2016.02.070","DOI":"10.1016\/j.cjca.2016.02.070"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Castorena-Gonzalez JA, Staiculescu MC, Foote C, Martinez-Lemus LA. Mechanisms of the Inward Remodeling Process in Resistance Vessels: Is the Actin Cytoskeleton Involved? Microcirculation. 2014;21(3):219\u201329. DOI: 10.1111\/micc.12105","DOI":"10.1111\/micc.12105"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Sato Y, Yamamoto E, Sawa T, Toda K, Hara T, Iwasaki T et al. Highsensitivity cardiac troponin T in essential hypertension. Journal of Cardiology. 2011;58(3):226\u201331. DOI: 10.1016\/j.jjcc.2011.07.009","DOI":"10.1016\/j.jjcc.2011.07.009"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Mancia G, Fagard R, Narkiewicz K, Red\u00f3n J, Zanchetti A, B\u00f6hm M et al. 2013 ESH\/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension. 2013;31(7):1281\u2013357. DOI: 10.1097\/01.hjh.0000431740.32696.cc","DOI":"10.1097\/01.hjh.0000431740.32696.cc"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Oliver JJ, Webb DJ, Newby DE. Stimulated Tissue Plasminogen Activator Release as a Marker of Endothelial Function in Humans. Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25(12):2470\u20139. DOI: 10.1161\/01.ATV.0000189309.05924.88","DOI":"10.1161\/01.ATV.0000189309.05924.88"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Burdick MM, Bochner BS, Collins BE, Schnaar RL, Konstantopoulos K. Glycolipids Support E-Selectin-Specific Strong Cell Tethering under Flow. Biochemical and Biophysical Research Communications. 2001;284(1):42\u20139. DOI: 10.1006\/bbrc.2001.4899","DOI":"10.1006\/bbrc.2001.4899"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Hamsten A. The hemostatic system and coronary heart disease. Thrombosis Research. 1993;70(1):1\u201338. DOI: 10.1016\/0049-3848(93)90221-9","DOI":"10.1016\/0049-3848(93)90221-9"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Over J, Sixma JJ, Bru\u00efne MH, Trieschnigg MC, Vlooswijk RA, Beeser-Visser NH et al. Survival of 125iodine-labeled Factor VIII in normals and patients with classic hemophilia. Observations on the heterogeneity of human Factor VIII. Journal of Clinical Investigation. 1978;62(2):223\u201334. DOI: 10.1172\/JCI109120","DOI":"10.1172\/JCI109120"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Ikeda U, Shimada K. Matrix metalloproteinases and coronary artery diseases. Clinical Cardiology. 2003;26(2):55\u20139. DOI: 10.1002\/clc.4960260203","DOI":"10.1002\/clc.4960260203"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Manna P, Jain SK. Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies. Metabolic Syndrome and Related Disorders. 2015;13(10):423\u2013 44. DOI: 10.1089\/met.2015.0095","DOI":"10.1089\/met.2015.0095"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G et al. Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease. Circulation. 2003;107(12):1579\u201385. DOI: 10.1161\/01.CIR.0000058700.41738.12","DOI":"10.1161\/01.CIR.0000058700.41738.12"},{"key":"ref16","unstructured":"Rogova L.N., Shesternina N.V., Zamechnik T.V., Fastova I.A. Matrix metalloproteinases, their role in physiological and pathological processes (review). Bulletin of New Medical Technologies. 2011;18(2):86\u20139."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Opgaard OS, Cantera L, Adner M, Edvinsson L. Endothelin-A and -B receptors in human coronary arteries and veins. Regulatory Peptides. 1996;63(2\u20133):149\u201356. DOI: 10.1016\/0167-0115(96)00036-5","DOI":"10.1016\/0167-0115(96)00036-5"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Vasina L.V., Petrishchev N.N., Vlasov T.D. Markers of endothelial dysfunction. Regional blood circulation and microcirculation. 2017;16(1):4\u201315. DOI: 10.24884\/1682-6655-2017-16-1-4-15","DOI":"10.24884\/1682-6655-2017-16-1-4-15"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Mourad J-J, Waeber B, Zannad F, Laville M, Duru G, Andr\u00e9jak M. Comparison of different therapeutic strategies in hypertension: a lowdose combination of perindopril\/indapamide versus a sequential monotherapy or a stepped-care approach. Journal of Hypertension. 2004;22(12):2379\u201386. DOI: 10.1097\/00004872-200412000-00021","DOI":"10.1097\/00004872-200412000-00021"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Chapman N, Huxley R, Anderson C, Bousser MG, Chalmers J, Colman S et al. Effects of a Perindopril-Based Blood Pressure\u2013Lowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History: The PROGRESS Trial. Stroke. 2004;35(1):116\u201321. DOI: 10.1161\/01.STR.0000106480.76217.6F","DOI":"10.1161\/01.STR.0000106480.76217.6F"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269\u2013324. DOI: 10.1161\/HYP.0000000000000066","DOI":"10.1161\/HYP.0000000000000075"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Toto RD, Rinner S, Ram CVS. ACE inhibitors and target organ protection: An expanded role for these antihypertensive agents? Postgraduate Medicine. 2004;116(2):11\u201348. DOI: 10.3810\/pgm.2004.08.1567","DOI":"10.3810\/pgm.2004.08.1567"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Flamant M, Placier S, Dubroca C, Esposito B, Lopes I, Chatziantoniou C et al. Role of Matrix Metalloproteinases in Early Hypertensive Vascular Remodeling. Hypertension. 2007;50(1):212\u20138. DOI: 10.1161\/HYPERTENSIONAHA.107.089631","DOI":"10.1161\/HYPERTENSIONAHA.107.089631"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Scientific Committee of the PERTINENT Sub-Study, EUROPAPERTINENT Investigators. PERTINENT \u2013 perindopril-thrombosis, inflammation, endothelial dysfunction and neurohormonal activation trial: a sub-study of the EUROPA study. Cardiovascular Drugs and Therapy. 2003;17(1):83\u201391. DOI: 10.1023\/a:1024394610648","DOI":"10.1023\/A:1024394610648"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet. 1998;352(9131):837\u201353. DOI: 10.1016\/S0140-6736(98)07019-6","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Brugts JJ, Boersma E, Chonchol M, Deckers JW, Bertrand M, Remme WJ et al. The Cardioprotective Effects of the AngiotensinConverting Enzyme Inhibitor Perindopril in Patients With Stable Coronary Artery Disease Are Not Modified by Mild to Moderate Renal Insufficiency: insights from the EUROPA trial. Journal of the American College of Cardiology. 2007;50(22):2148\u201355. DOI: 10.1016\/j.jacc.2007.08.029","DOI":"10.1016\/j.jacc.2007.08.029"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Moskalenko M.I. The involvement of genes of matrix metalloproteinases in the development of arterial hypertension and its complication (review). Research Result. Medicine and Pharmacy. 2018;4(1):53\u2013 69. DOI: 10.18413\/2313-8955-2018-4-1-53-69","DOI":"10.18413\/2313-8955-2018-4-1-53-69"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Falkovskaya A.Yu., Mordovin V.F., Pekarskiy S.E., Ripp T.M., Zyubanova I.V., Sitkova E.S. et al. Matrix metalloproteinases in patients with resistant hypertension and type 2 diabetes mellitus: relation with renal blood flow and kidney function. Arterial Hypertension. 2019;25(1):34\u201345. DOI: 10.18705\/1607-419X-2019-25-1-34-45","DOI":"10.18705\/1607-419X-2019-25-1-34-45"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Daiber A, Steven S, Weber A, Shuvaev VV, Muzykantov VR, Laher I et al. Targeting vascular (endothelial) dysfunction: Targeting vascular (endothelial) dysfunction. British Journal of Pharmacology. 2017;174(12):1591\u2013619. DOI: 10.1111\/bph.13517","DOI":"10.1111\/bph.13517"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Giles LV, Tebbutt SJ, Carlsten C, Koehle MS. The effect of low and high-intensity cycling in diesel exhaust on flow-mediated dilation, circulating NOx, endothelin-1 and blood pressure. PLOS ONE. 2018;13(2):e0192419. DOI: 10.1371\/journal.pone.0192419","DOI":"10.1371\/journal.pone.0192419"},{"key":"ref31","unstructured":"Stepanova Yu.I., Gonchar I.A. Endothelin-dependent effects in cerebrovascular pathology of ischemic genesis. Medical news. 2013;10:12\u20138."},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Hlubock\u00e1 Z, Umnerov\u00e1 V, Heller S, Peleska J, Jindra A, J\u00e1chymov\u00e1 M et al. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors. Journal of Human Hypertension. 2002;16(8):557\u201362. DOI: 10.1038\/sj.jhh.1001403","DOI":"10.1038\/sj.jhh.1001403"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Valente FM, de Andrade DO, Cosenso-Martin LN, Cesarino CB, Guimar\u00e3es SM, Guimar\u00e3es VB et al. Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis. BMC Cardiovascular Disorders. 2020;20(1):132. DOI: 10.1186\/s12872-020-01412-5","DOI":"10.1186\/s12872-020-01412-5"}],"container-title":["Kardiologiia"],"original-title":[],"link":[{"URL":"https:\/\/lib.ossn.ru\/jour\/article\/viewFile\/1890\/1149","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:16:15Z","timestamp":1793639775000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardio.elpub.ru\/jour\/article\/view\/1890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,31]]}},"URL":"https:\/\/doi.org\/10.18087\/cardio.2022.1.n1890","relation":{},"ISSN":["2412-5660","0022-9040"],"issn-type":[{"value":"2412-5660","type":"electronic"},{"value":"0022-9040","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,31]]}}}